| dbo:abstract
|
- LifeArc is a British life science medical research charity. It was established in 2000 as MRC Technology to translate the work of UK Medical Research Council (MRC) research scientists. Today, LifeArc provides intellectual property identification, protection and commercialisation, technology development, diagnostic development, early stage drug discovery and antibody humanization services for the MRC, academia, biotechnology and pharmaceutical organisations and charities, aiming to move promising medical research forward into viable and accessible patient treatments. Profits from LifeArc's activities are reinvested into further research. LifeArc uses funds from royalty payments to provide grants into rare disease research and allocates seed funding to UK companies. (en)
|
| dbo:fate
|
- Renamed LifeArc in 2017 (en)
|
| dbo:foundingYear
| |
| dbo:industry
| |
| dbo:keyPerson
| |
| dbo:numberOfEmployees
|
- 180 (xsd:nonNegativeInteger)
|
| dbo:revenue
| |
| dbo:service
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 8667 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:fate
|
- Renamed LifeArc in 2017 (en)
|
| dbp:foundation
| |
| dbp:industry
|
- Life science medical research charity (en)
|
| dbp:keyPeople
|
- (en)
- Dr John Stageman
Melanie Lee (en)
|
| dbp:locationCity
| |
| dbp:locationCountry
| |
| dbp:locations
|
- London, Stevenage, Edinburgh (en)
|
| dbp:logo
| |
| dbp:name
| |
| dbp:numEmployees
| |
| dbp:revenue
|
- (en)
- £1,204.7million (en)
|
| dbp:services
|
- IP management, drug discovery, diagnostics development, antibody engineering, charity portfolio review (en)
|
| dbp:type
|
- Charity Commission for England and Wales (en)
|
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- LifeArc is a British life science medical research charity. It was established in 2000 as MRC Technology to translate the work of UK Medical Research Council (MRC) research scientists. Today, LifeArc provides intellectual property identification, protection and commercialisation, technology development, diagnostic development, early stage drug discovery and antibody humanization services for the MRC, academia, biotechnology and pharmaceutical organisations and charities, aiming to move promising medical research forward into viable and accessible patient treatments. Profits from LifeArc's activities are reinvested into further research. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
